Videos

Featured

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís, et al

Watch time: 41m 52s

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Mikhail Kosiborod

ACC 24 Late-Breaker Discussion: The AEGIS-II Trial

Harriette Van Spall, Michael C Gibson

Watch time: 14m 7s

Navdeep Tangri, James Burton, David Wheeler et al

James Burton, David Wheeler, Carol Pollock, et al

THT 24: The ALT FLOW Early Feasibility Study

Firas Zahr

Watch time: 4m 3s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s
ACC.24: The STEP HFpEF DM Trial

Mikhail Kosiborod

Watch time: 6m 41s
Artificial Intelligence in Cardiology: What You Need to Know in 2024

Ami Bhatt

Watch time: 6m 45s
ACC 24 Late-Breaker Discussion: The EMPACT-MI Trial

Harriette Van Spall, Javed Butler

Watch time: 22m 43s

Trending

Antoni Bayés-Genís, Lisa Anderson, Stephen J Greene et al

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s (11 videos)

Óscar Cano, Marek Jastrzębski, Pugazhendhi Vijayaraman, et al

Watch time: 1h 2m 39s

Anjay Rastogi

Ahmad Masri, Ahmad Masri, Thibaud Damy et al

Julian Gillmore, Margot K Davis, Ahmad Masri, et al

Watch time: 58m 35s (5 videos)

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís et al

Javed Butler, Shelley Zieroth, Gianluigi Savarese et al

Owais Dar, Espeed Khoshbin

Julia Vogler

Watch time: 1h 25m 50s (7 videos) (10 videos)

Events

Filter by

AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
AHA 24: The REMS Program for Mavacamten

Milind Y Desai

Watch time: 7m 19s
AHA 24: The VALOR-HCM Trial

Milind Y Desai

Watch time: 10m 31s
AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
TCT 24: The MATTERHORN Trial

Stephan Baldus

Watch time: 5m 36s
TCT 24: The TAVR UNLOAD Trial

Nicolas M Van Mieghem

Watch time: 4m 10s
View from the Thoraxcenter: What's Hot at AHA 24?

Joost Daemen, Nicolas M Van Mieghem

Watch time: 13m 43s
HFSA 24: STEP-HFpEF: Exercise Function and Frailty Status

Mikhail Kosiborod

Watch time: 12m 9s
HFSA 24: The HuMAIN-HFpEF Trial

Ambarish Pandey

Watch time: 4m 5s
HFSA 24: The EMBARK HFpEF Trial

Watch time: 7m 11s

Latest

Filter by

ESC 2018: Rationale for New Treatment Options for Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 19m 4s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Andrew SP Sharp, Adriaan Kraaijeveld, Nicolas Meneveau, et al

Watch time: 14m 32s
ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes

Javed Butler, Stefan Anker

Watch time: 9m 24s
Symposium at ESC Congress 2018 sponsored by EKOS Corporation

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 5m 49s
TCT 2018: SYNTAXES

Daniel JFM Thuijs

Watch time: 2m 58s
TCT 2018: RADIOSOUND-HTN

Philipp Lurz

Watch time: 3m 27s